Evaluation of object-based attention in mice

Behavioural Brain Research

Volumn 220, Issue 1, 2011, Pages 185-193

  Alkam, Tursun ^a,b,g   Hiramatsu, Masayuki ^a,b,c   Mamiya, Takayoshi ^a,b,c   Aoyama, Yuki ^a   Nitta, Atsumi ^c,d   Yamada, Kiyofumi ^c,e   Kim, Hyoung Chun ^f   Nabeshima, Toshitaka ^a,b,c  

^a MEIJO UNIVERSITY   (Japan)

^b The Academic Frontier Project for Private Universities   (Japan)

^c Japanese Drug Organization of Appropriate Use and Research   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f Kangwon National University   (South Korea)

^g Department of Basic Medicine   (China)

Author keywords

Mouse; Object based attention; PCP; PCPA; Working memory

Indexed keywords

DOPAMINE; FENCLONINE; NORADRENALIN; PHENCYCLIDINE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; AUDITORY RESPONSE; CONTROLLED STUDY; LONG TERM MEMORY; MEMORY DISORDER; MOUSE; NONHUMAN; OBJECT RELATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DEPLETION; RECOGNITION; SHORT TERM MEMORY; TASK PERFORMANCE; WORKING MEMORY;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FENCLONINE; INHIBITION (PSYCHOLOGY); MALE; MAZE LEARNING; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; NEUROPSYCHOLOGICAL TESTS; NOREPINEPHRINE; PHENCYCLIDINE; RECOGNITION (PSYCHOLOGY); SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 79952096735     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.01.039     Document Type: Article

References (60)

1. DasBanerjee T., Middleton F.A., Berger D.F., Lombardo J.P., Sagvolden T., Faraone S.V. A comparison of molecular alterations in environmental and genetic rat models of ADHD: a pilot study. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1554-1563.
2. Kostrzewa R.M., Kostrzewa J.P., Kostrzewa R.A., Nowak P., Brus R. Pharmacological models of ADHD. J Neural Transm 2008, 115:287-298.
3. Russell V.A. Neurobiology of animal models of attention-deficit hyperactivity disorder. J Neurosci Methods 2007, 161:185-198.
4. Russell V.A., Sagvolden T., Johansen E.B. Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct 2005, 1:9.
5. van der Kooij M.A., Glennon J.C. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. Neurosci Biobehav Rev 2007, 31:597-618.
6. Viggiano D., Ruocco L.A., Arcieri S., Sadile A.G. Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder. Neural Plast 2004, 11:133-149.
7. Carli M., Robbins T.W., Evenden J.L., Everitt B.J. Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 1983, 9:361-380.
8. Humby T., Laird F.M., Davies W., Wilkinson L.S. Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. Eur J Neurosci 1999, 11:2813-2823.
9. Anisman H., McIntyre D.C. Conceptual, spatial, and cue learning in the Morris water maze in fast or slow kindling rats: attention deficit comorbidity. J Neurosci 2002, 22:7809-7817.
10. Pichat P., Bergis O.E., Terranova J.P., Urani A., Duarte C., Santucci V., et al. SSR 180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology 2007, 32:17-34.
11. Bari A., Dalley J.W., Robbins T.W. The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat Protoc 2008, 3:759-767.
12. Marston H.M., Spratt C., Kelly J.S. Phenotyping complex behaviours: assessment of circadian control and 5-choice serial reaction learning in the mouse. Behav Brain Res 2001, 125:189-193.
13. Tucci V., Hardy A., Nolan P.M. A comparison of physiological and behavioural parameters in C57BL/6J mice undergoing food or water restriction regimes. Behav Brain Res 2006, 173:22-29.
14. Steckler T., Sauvage M., Holsboer F. Glucocorticoid receptor impairment enhances impulsive responding in transgenic mice performing on a simultaneous visual discrimination task. Eur J Neurosci 2000, 12:2559-2569.
15. Hritcu L., Clicinschi M., Nabeshima T. Brain serotonin depletion impairs short-term memory, but not long-term memory in rats. Physiol Behav 2007, 91:652-657.
16. Noda A., Noda Y., Kamei H., Ichihara K., Mamiya T., Nagai T., et al. Phencyclidine impairs latent learning in mice: interaction between glutamatergic systems and sigma(1) receptors. Neuropsychopharmacology 2001, 24:451-460.
17. Bakshi V.P., Geyer M.A. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist. J Pharmacol Exp Ther 1997, 283:666-674.
18. Mori A., Noda Y., Nagai T., Mamiya T., Furukawa H., Nabeshima T. Involvement of dopaminergic system in the nucleus accumbens in the discriminative stimulus effects of phencyclidine. Neuropharmacology 2002, 42:764-771.
19. Mizoguchi H., Arai S., Koike H., Ibi D., Kamei H., Nabeshima T., et al. Therapeutic potential of nicotine for methamphetamine-induced impairment of sensorimotor gating: involvement of pallidotegmental neurons. Psychopharmacology (Berl) 2009, 207:235-243.
20. Alkam T., Nitta A., Mizoguchi H., Itoh A., Nabeshima T. A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Abeta(25-35). Behav Brain Res 2007, 180:139-145.
21. Kamei H., Nagai T., Nakano H., Togan Y., Takayanagi M., Takahashi K., et al. Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice. Biol Psychiatry 2006, 59:75-84.
22. Tsunekawa H., Noda Y., Mouri A., Yoneda F., Nabeshima T. Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35). Behav Brain Res 2008, 190:224-232.
23. Myskiw J.C., Rossato J.I., Bevilaqua L.R., Medina J.H., Izquierdo I., Cammarota M. On the participation of mTOR in recognition memory. Neurobiol Learn Mem 2008, 89:338-351.
24. Clarke J.R., Cammarota M., Gruart A., Izquierdo I., Delgado-Garcia J.M. Plastic modifications induced by object recognition memory processing. Proc Natl Acad Sci U S A 2010, 107:2652-2657.
25. Alkam T., Nitta A., Furukawa-Hibi Y., Niwa M., Mizoguchi H., Yamada K., et al. Oral supplementation with Leu-Ile, a hydrophobic dipeptide, prevents the impairment of memory induced by amyloid beta in mice via restraining the hyperphosphorylation of extracellular signal-regulated kinase. Behav Brain Res 2010, 210:184-190.
26. Ernst M., Liebenauer L.L., Tebeka D., Jons P.H., Eisenhofer G., Murphy D.L., et al. Selegiline in ADHD adults: plasma monoamines and monoamine metabolites. Neuropsychopharmacology 1997, 16:276-284.
27. Spencer T.J., Biederman J., Mick E. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol 2007, 32:631-642.
28. Halperin J.M., Newcorn J.H., Koda V.H., Pick L., McKay K.E., Knott P. Noradrenergic mechanisms in ADHD children with and without reading disabilities: a replication and extension. J Am Acad Child Adolesc Psychiatry 1997, 36:1688-1697.
29. Baunez C., Robbins T.W. Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat. Neuroscience 1999, 92:1343-1356.
30. Harrison A.A., Everitt B.J., Robbins T.W. Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination. Behav Brain Res 1999, 100:99-112.
31. Masaki D., Yokoyama C., Kinoshita S., Tsuchida H., Nakatomi Y., Yoshimoto K., et al. Relationship between limbic and cortical 5-HT neurotransmission and acquisition and reversal learning in a go/no-go task in rats. Psychopharmacology (Berl) 2006, 189:249-258.
32. Navarra R., Graf R., Huang Y., Logue S., Comery T., Hughes Z., et al. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:34-41.
33. Bymaster F.P., Katner J.S., Nelson D.L., Hemrick-Luecke S.K., Threlkeld P.G., Heiligenstein J.H., et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002, 27:699-711.
34. Biederman J., Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 1999, 46:1234-1242.
35. Jakala P., Sirvio J., Jolkkonen J., Riekkinen P., Acsady L., Riekkinen P. The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task. Behav Brain Res 1992, 51:29-40.
36. Boulougouris V., Tsaltas E. Serotonergic and dopaminergic modulation of attentional processes. Prog Brain Res 2008, 172:517-542.
37. Nabeshima T., Mouri A., Murai R., Noda Y. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine. Ann N Y Acad Sci 2006, 1086:160-168.
38. Faraone S.V., Sergeant J., Gillberg C., Biederman J. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry 2003, 2:104-113.
39. Viggiano D., Vallone D., Ruocco L.A., Sadile A.G. Behavioural, pharmacological, morpho-functional molecular studies reveal a hyperfunctioning mesocortical dopamine system in an animal model of attention deficit and hyperactivity disorder. Neurosci Biobehav Rev 2003, 27:683-689.
40. Lubow R.E. Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophr Bull 2005, 31:139-153.
41. Chudasama Y., Robbins T.W. Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia. Psychopharmacology (Berl) 2004, 174:86-98.
42. Robbins T.W. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 2002, 163:362-380.
43. Jones D.N., Higgins G.A. Effect of scopolamine on visual attention in rats. Psychopharmacology (Berl) 1995, 120:142-149.
44. Patel S., Stolerman I.P., Asherson P., Sluyter F. Attentional performance of C57BL/6 and DBA/2 mice in the 5-choice serial reaction time task. Behav Brain Res 2006, 170:197-203.
45. Tagliamonte A., Tagliamonte P., Corsini G.U., Mereu G.P., Gessa G.L. Decreased conversion of tyrosine to catecholamines in the brain of rats treated with p-chlorophenylalanine. J Pharm Pharmacol 1973, 25:101-103.
46. Di Matteo V., De Blasi A., Di Giulio C., Esposito E. Role of 5-HT(2C) receptors in the control of central dopamine function. Trends Pharmacol Sci 2001, 22:229-232.
47. Cole B.J., Robbins T.W. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res 1989, 33:165-179.
48. Arnsten A.F. Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 1997, 11:151-162.
49. Stahl S.M. The prefrontal cortex is out of tune in attention-deficit/hyperactivity disorder. J Clin Psychiatry 2009, 70:950-951.
50. Passingham D., Sakai K. The prefrontal cortex and working memory: physiology and brain imaging. Curr Opin Neurobiol 2004, 14:163-168.
51. Lee D., Rushworth M.F., Walton M.E., Watanabe M., Sakagami M. Functional specialization of the primate frontal cortex during decision making. J Neurosci 2007, 27:8170-8173.
52. Messinger A., Lebedev M.A., Kralik J.D., Wise S.P. Multitasking of attention and memory functions in the primate prefrontal cortex. J Neurosci 2009, 29:5640-5653.
53. Kane M.J., Engle R.W. The role of prefrontal cortex in working-memory capacity, executive attention, and general fluid intelligence: an individual-differences perspective. Psychon Bull Rev 2002, 9:637-671.
54. Daffner K.R., Mesulam M.M., Scinto L.F., Acar D., Calvo V., Faust R., et al. The central role of the prefrontal cortex in directing attention to novel events. Brain 2000, 123(Pt 5):927-939.
55. Lebedev M.A., Messinger A., Kralik J.D., Wise S.P. Representation of attended versus remembered locations in prefrontal cortex. PLoS Biol 2004, 2:e365.
56. Jentsch J.D., Tran A., Le D., Youngren K.D., Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 1997, 17:92-99.
57. Stefani M.R., Moghaddam B. Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat. Behav Brain Res 2002, 134:267-274.
58. Mouri A., Noda Y., Noda A., Nakamura T., Tokura T., Yura Y., et al. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine. Mol Pharmacol 2007, 71:1598-1609.
59. Mouri A., Noda Y., Enomoto T., Nabeshima T. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochem Int 2007, 51:173-184.
60. Greco B., Invernizzi R.W., Carli M. Phencyclidine-induced impairment in attention and response control depends on the background genotype of mice: reversal by the mGLU(2/3) receptor agonist LY379268. Psychopharmacology (Berl) 2005, 179:68-76.